These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


98 related items for PubMed ID: 1463341

  • 1. [Sensitivity test for anti-tumor agents-3. MTT assay and its clinical effect].
    Wada Y, Tomiyoshi Y, Fujimaru J, Ogura M, Hirabayashi K, Yoshida S, Takeda Y.
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2349-54. PubMed ID: 1463341
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Sensitivity test of anti-tumor agents. 2. Application of MTT assay].
    Wada Y, Tomiyoshi Y, Fujimaru J, Ogura M, Yoshida S, Takeda Y.
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1587-92. PubMed ID: 1908212
    [Abstract] [Full Text] [Related]

  • 4. [In vitro chemosensitivity test for seven undifferentiated thyroid carcinoma cell lines using MTT assay].
    Osawa Y, Yoshida A, Asaga T, Kawahara S, Yanoma S.
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):471-6. PubMed ID: 8678500
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Establishment of transplantable human colon cancer cell lines, chemosensitivity of colon carcinomas and the serially transplantable strains with MTT assay].
    Kase S, Kubota T, Furukawa T, Yamaguchi H, Takeuchi T, Takahara T, Suto A, Kodaira S, Ishibiki K.
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2247-53. PubMed ID: 1929445
    [Abstract] [Full Text] [Related]

  • 7. [Chemosensitivity test for gastric cancer by in vitro MTT assay].
    Ohyama S, Yonemura Y, Kinoshita K, Ninomiya I, Tugawa K, Kimura H, Miyazaki I, Tanaka M, Endo Y, Sasaki T.
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1593-7. PubMed ID: 1908213
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [A trial of isolation in chemotherapy for gynecological malignant tumor by MTT assay].
    Sato Y, Igarashi S, Higuchi J, Soga K, Tanaka T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Dec; 45(12):1421-4. PubMed ID: 8270830
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A new in vitro chemosensitivity test. Individualized chemotherapy against ovarian cancer and its clinical effect].
    Takamizawa H, Sekiya S, Iwasawa H, Ishige H, Tokita H, Tanaka N.
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2293-7. PubMed ID: 2416274
    [Abstract] [Full Text] [Related]

  • 13. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents.
    Fricker SP, Buckley RG.
    Anticancer Res; 1996 Dec; 16(6B):3755-60. PubMed ID: 9042253
    [Abstract] [Full Text] [Related]

  • 14. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
    Konecny G, Crohns C, Pegram M, Felber M, Lude S, Kurbacher C, Cree IA, Hepp H, Untch M.
    Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
    [Abstract] [Full Text] [Related]

  • 15. Independent antitumor spectrum of UCN-01 (7-hydroxystaurosporine) against gastric and colorectal cancers as detected by MTT assay.
    Abe S, Kubota T, Saikawa Y, Otani Y, Furukawa T, Watanabe M, Kumai K, Kitajima M.
    Anticancer Res; 2002 May; 22(6B):3605-10. PubMed ID: 12552963
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.
    Ohie S, Udagawa Y, Kozu A, Komuro Y, Aoki D, Nozawa S, Moossa AR, Hoffman RM.
    Anticancer Res; 2000 May; 20(3B):2049-54. PubMed ID: 10928150
    [Abstract] [Full Text] [Related]

  • 17. Interference by anti-cancer chemotherapeutic agents in the MTT-tumor chemosensitivity assay.
    Ulukaya E, Colakogullari M, Wood EJ.
    Chemotherapy; 2004 Apr; 50(1):43-50. PubMed ID: 15084806
    [Abstract] [Full Text] [Related]

  • 18. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
    Shi W, Gu M, Liang L.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
    [Abstract] [Full Text] [Related]

  • 19. The identification of drug resistance in ovarian cancer and breast cancer: application of the MTT assay.
    Sargent J, Elgie A, Taylor CG, Wilson J, Alton P, Hill JG.
    Contrib Gynecol Obstet; 1994 Feb; 19():64-75. PubMed ID: 7995054
    [No Abstract] [Full Text] [Related]

  • 20. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
    Haselsberger K, Peterson DC, Thomas DG, Darling JL.
    Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.